Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Fanti, B.A. (B. A.) de | - |
| dc.creator | Lamas, O. (Óscar) | - |
| dc.creator | Milagro-Yoldi, F.I. (Fermín Ignacio) | - |
| dc.creator | Martinez-Anso, E. (Eduardo) | - |
| dc.creator | Martinez, J.A. (José Alfredo) | - |
| dc.date.accessioned | 2011-04-20T15:09:53Z | - |
| dc.date.available | 2011-04-20T15:09:53Z | - |
| dc.date.issued | 2002 | - |
| dc.identifier.citation | De Fanti BA, Lamas O, Milagro FI, Martinez-Anso E, Martinez JA. Immunoneutralization and anti-idiotype production: two-sided applications of leptin. Trends Immunol 2002 Apr;23(4):180-181. | es_ES |
| dc.identifier.issn | 1471-4906 | - |
| dc.identifier.uri | https://hdl.handle.net/10171/17848 | - |
| dc.description.abstract | The neuroendocrine and immune systems are linked through a complex bi-directional network, in which hormones modify immune function, and the immune system, through the action of cytokines, affects neuroendocrine responses involved in the maintenance of body homeostasis. The adipocyte-derived, peptide hormone leptin is a pleiotropic molecule belonging to the helical cytokine family. On pp. 182-187, Matarese et al. suggest the possibility of new leptin-based therapeutic strategies for the treatment of both infection and autoimmune disease. | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Elsevier | es_ES |
| dc.rights | info:eu-repo/semantics/openAccess | es_ES |
| dc.subject | Leptin | es_ES |
| dc.subject | Immune systems | es_ES |
| dc.title | Immunoneutralization and anti-idiotype production: two-sided applications of leptin | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.relation.publisherversion | http://linkinghub.elsevier.com/retrieve/pii/S1471490602022019 | es_ES |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.
